Impact of HTLV-I in quality of life and urogynecologic parameters of women with urinary incontinence

Diniz, Monica Suzana Costa; Feldner, Paulo Cezar; Castro, Rodrigo Aquino; Sartori, Marair Grácio Ferreira; Girão, Manoel Joâo Batista Castello

doi:10.1016/j.ejogrb.2009.07.024

Cited by 18 publications

(26 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A previous study that compared the impact of urinary incontinence in the quality of life of women infected with HTLV-1 with uninfected women showed that infected women had worse quality of life in the domains of general health perception, social relations, and sleep and mood aspects, in addition to limitations in their activities of daily life (14). However, the study was limited due to heterogeneity in disease stage classification of the study population.…”

Section: Discussionmentioning

confidence: 94%

Association between urinary symptoms and quality of life in HTLV-1 infected subjects without myelopathy

et al. 2013

View full text Add to dashboard Cite

Objective: To investigate the relationship between urinary symptoms and quality of life of patients infected with HTLV-1. Materials and Methods: This is a cross-sectional study that enrolled individuals with HTLV-1 positive serology from February 2010 to March 2011. Participants were HTLV-1 infected subjects followed in the HTLV-1 clinic of the University Hospital in Salvador, Bahia, Brazil. Patients with HTLV-1 associated myelopathy / tropical spastic paraparesis (HAM/TSP), who had evidence of other neurological diseases, diabetes mellitus or were pregnant were excluded from the study. The questionnaire SF-36 was used to evaluate quality of life and the questionnaire OAB-V8 was used to evaluate urinary symptoms. Results: From the 118 individuals evaluated, 50 (42.4%) complained of urinary symptoms and 68 (57.6%) did not. Most participants were females. There was no difference between the groups regarding demographic variables. The group with symptoms showed significantly lower scores in all domains of the SF-36 questionnaire. The domains with greatest differences were vitality and general health state. Conclusions: Urinary symptoms negatively influence the quality of life of individuals infected with HTLV-1.Association between urinary symptoms and quality of life in hTLV-1 infected subjects without myelopathy _______________________________________________

show abstract

Section: Discussionmentioning

confidence: 94%

Association between urinary symptoms and quality of life in HTLV-1 infected subjects without myelopathy

et al. 2013

View full text Add to dashboard Cite

show abstract

“…Urinary symptoms are found in the early stages of the disease 18 and are considered important factors that worsen the quality of life of patients with HAM/TSP. Patients with better bladder control had higher scores in the domain of functional capacity.…”

Section: Discussionmentioning

confidence: 99%

Quality of life in patients with HTLV-I associated myelopathy/tropical spastic paraparesis

Martins

Baptista

Araújo

2012

Arq. Neuro-Psiquiatr.

View full text Add to dashboard Cite

OBJECTIVE: To assess the quality of life (QoL) of patients with HTLV-I-associate myelopathy/tropical spastic paraparesis (HAM/TSP) and to correlate it with specific aspects of the disease. METHODS: Fifty-seven HAM/TSP patients completed the SF-36 QoL questionnaire. They were also asked about common complaints related to the disease, and we looked for associations between QoL and these complaints. RESULTS: Patients with HAM/TSP showed a strong negative association to QoL. Pain was the condition which most affected their QoL. The practice of physical activity is associated with better QoL in five out of eight domains of the scale. CONCLUSION: HAM/TSP leads to a poor QoL, mostly influenced by pain. Physical activity may have a positive association to QoL of these patients.

show abstract

“…Moreover, the urinary symptoms of OAB may be the fi rst manifestation of HAM/TSP 1,4 . Urinary manifestations are important complaints of HTLV-1-infected patients that decrease their quality of life and ability to work 5,6 . Some patients experience voiding dysfunction and underactivity of the detrusor or detrusor arefl exia that requires intermittent self-catheterization 6 .…”

mentioning

confidence: 99%

“…Urinary manifestations are important complaints of HTLV-1-infected patients that decrease their quality of life and ability to work 5,6 . Some patients experience voiding dysfunction and underactivity of the detrusor or detrusor arefl exia that requires intermittent self-catheterization 6 . The relationship between HTLV-1 infection and OAB is well documented.…”

mentioning

confidence: 99%

The use of botulinum toxin type A in the treatment of HTLV-1-associated overactive bladder refractory to conventional therapy

Neto

Bittencourt

Oliveira

et al. 2014

Rev. Soc. Bras. Med. Trop.

View full text Add to dashboard Cite

Urinary symptoms occur in 19% of human T-cell lymphotropic virus type 1 (HTLV-1)-infected patients who do not fulfi ll criteria for HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) and in almost 100% of HAM/TSP patients. Few studies have evaluated therapies for overactive bladder (OAB) caused by HTLV-1 infection. This case report describes the effect of onabotulinum toxin A on the urinary manifestations of three patients with HAM/TSP and OAB symptoms. The patients were intravesically administered 200 units of Botox®. Their incontinence episodes improved, and their OAB symptoms scores (OABSS) reduced signifi cantly. These data indicate that Botox® should be a treatment option for OAB associated with HTLV-1 infection.

show abstract

Impact of HTLV-I in quality of life and urogynecologic parameters of women with urinary incontinence

Cited by 18 publications

References 21 publications

Association between urinary symptoms and quality of life in HTLV-1 infected subjects without myelopathy

Association between urinary symptoms and quality of life in HTLV-1 infected subjects without myelopathy

Quality of life in patients with HTLV-I associated myelopathy/tropical spastic paraparesis

The use of botulinum toxin type A in the treatment of HTLV-1-associated overactive bladder refractory to conventional therapy

Contact Info

Product

Resources

About